Apply for the AVITI for Oncology Grant

Accelerate your cancer research project with the 2024 AVITI for Oncology Grant, sponsored by Element and AmpSeq.

AVITI On Photo

Demand more from your sequencer—for less.

With the AVITI System, Element has rethought every aspect of sequencing with our end users’ needs in mind. The system is designed to do more by delivering industry-leading accuracy at low run costs—so you can do more.

>90% Q30Unprecedented Quality
$1 CostPer Million Reads
Dual Flow CellsCompletely Independent
Discover avidity base chemistry (ABC)

Learn about our innovative technology that leverages unique, proprietary avidites to deliver highly accurate data, more efficiently—all in a compact benchtop design for labs of any size.

What are others saying about Element?

Jumpcode Genomics

"…The sequencing quality of the AVITI System when compared side by side to other sequencing platforms was remarkable. The AVITI showed measurably higher percent unique alignment to hg38 and a significantly lower percent duplication rate…"

Jon ArmstrongVice President of Research & Development

Agilent Technologies, Inc.

"Our SureSelect brand of target enrichment solutions is a very important trusted product line with our customers so we were very happy to report that the compatibility and data quality from the Element AVITI System was excellent, enabling highly-sensitive detection of variants when combined with our SureSelect panels."

Ronda AllenVice President and General Manager, Genomics Division

Gencove

"…We were impressed with how the AVITI System outperformed the reference sequencer when compared side by side, showing higher effective genome coverage especially on challenging sample types including FFPE samples."

Joseph Pickrell, PhDCEO

New England BioLabs

"Our experience with the Element customer support has been great! The installation process was done well and to our expectations. They are highly responsive when we have questions or need guidance or support."

Pingfang Liu, PhDApplications and Product Development Scientist

10x Genomics

"We are excited to see the AVITI System easily achieve our CPP requirements for single cell analysis to expand the number of options customers can choose from to access the technology…"

Jens Durruthy, PhDDirector Product Management, 10X Genomics